4-Chloro-2-(3-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde

Catalog No. :
ACWUVG410
CAS No. :
1493942-59-8
Molecular Formula :
C9H11ClN2O2S
Molecular Weight :
246.72

IUPAC Name:4-chloro-2-(3-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde

4-Chloro-2-(3-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$83.00Login to see priceIn stockInquiry
100mg95%$140.00Login to see priceIn stockIn stock
250mg95%$235.00Login to see priceIn stockIn stock
1g95%$711.00Login to see priceIn stockIn stock
5g95%$3234.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-2-(3-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde
IUPAC Name4-chloro-2-(3-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde
MDL No.MFCD23715361
Molecular FormulaC9H11ClN2O2S
Molecular Weight246.72
SMILESO=CC1=C(Cl)N=C(N2CC(O)CCC2)S1
InChI KeyVSKKTYAILWWZHG-UHFFFAOYSA-N
Synonym5-Thiazolecarboxaldehyde, 4-chloro-2-(3-hydroxy-1-piperidinyl)-;4-Chloro-2-(3-hydroxypiperidin-1-yl)thiazole-5-carbaldehyde
CAS No.1493942-59-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACWUVG410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWUVG410 route product structure diagram
    ACWUVG4101493942-59-8 In Stock
Inquiry

2. ACWUVG410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWUVG410 route product structure diagram
    ACWUVG4101493942-59-8 In Stock
Inquiry

Comments (0)